SC
MREO

Shay Capital’s Mereo BioPharma MREO Stock Holding History

Shay Capital’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-48,052
Closed -$77K – 603
2021
Q4 		$77K Buy
+48,052
New +$96.1K 0.01% 410
2021
Q3 		– Sell
-12,686
Closed -$40K – 645
2021
Q2 		$40K Sell
12,686
-4,581
-27% -$15.4K ﹤0.01% 496
2021
Q1 		$58K Sell
17,267
-148,544
-90% -$525K 0.01% 453
2020
Q4 		$594K Buy
+165,811
New +$415K 0.13% 144

Other funds holding MREO

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Shay Capital's MREO Position: Q1 2022 in Review

Shay Capital sold out of Mereo BioPharma (MREO) in Q1 2022, closing a stake of 48,052 shares — an estimated $77K sold.

Shay Capital first reported a position in MREO in Q4 2020 and held it in 4 quarters. The position peaked at $594K in Q4 2020. 60 funds tracked by Wall St. Rank hold MREO as of Q1 2022.

  • Shay Capital reported no remaining Mereo BioPharma position as of Q1 2022 after selling out during the quarter.
  • Shay Capital sold 48,052 Mereo BioPharma shares in Q1 2022, an estimated $77K.
  • Shay Capital first reported a position in Mereo BioPharma in Q4 2020 and held it in 4 quarters.
  • Shay Capital's Mereo BioPharma position peaked at $594K in Q4 2020.
  • 60 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2022.

Based on Shay Capital's 13F filing for Q1 2022, filed 16 May 2022.